A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

NCT04220762 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

188

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: WIN-1001X
DRUG: Placebo

Sponsor

Medi Help Line